A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects

Clinical trial NCT03155503 · COMPLETED

Trial details

NCT number: NCT03155503
Sponsor: Suven Life Sciences Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2017-05-22
Primary completion: 2018-03-07
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.